2Liedtke C,Broglio K,Moulder S,et al.Prognostic impact of discord- ance between triple-receptor measurements in primary and recurrent breast cancer[J].Ann oncol,2009,20(12):1953-1958.
3Rakha EAiEl-Sayed M E,Green AR,et al.Prognostic markers in tri- ple-negative breast cancer[J].Cancer,2007,109(1):25-32.
4Wirapati P,Sotirlou C,Kunkel S,et al.Meta-analysis of gene expres- sion profiles in breast cancer:toward a unified understanding of breast cancer subtyping and prognosis signa-tures[J].Breast Cancer Res,2008,10(4):1165.
5Nielsen TO,Hsu FD,Jensen K,et al.Immunohistochemical and clini- cal characterization of the basal-like subtype of invasive breast carci- noma[J].Clin Cancer Bes,2004,10(16):5367-5374.
6Haffty BG,Yang QF,Reiss M,et al.Locoregional Relapse and Distant Me,tastaais in Conservatively Managed Triple Negative Early-Stage Breast Cancer[J].J Clin Oneol,2006,24(36):5652-5657.
7Carey LA,Perou CM,Livasy CA,et al.Race,breast cancer subtypes,and survival in the Carolina Breast Cancer Study[J].JAMA,2006,295(21):2492-2502.
8Carey LA,Dees EC,Sawyer L,et al.The triple negative paradox._pri- mary tumor ehemosensitivity of breast cancer subtypes[J].Clin Canc- er Res,2007,13(8):2329-2334.
